This was on Westpac.
Mesoblast has successfully met the pre-specified primary endpoint, prospectively agreed with FDA, of a single-arm Phase 3 trial in 54 children with SR-aGvHD. While the Oncologic Drugs Advisory Committee of FDA in August 2020 voted 9:1 in favor of remestemcel-L’s efficacy in a pediatric patient population, in September 2020 FDA recommended further steps be undertaken to obtain approval. The BLA resubmission of January 2023 included long-term follow-up data from the Phase 3 trial by the Center for International Blood and Marrow Transplant Research (CIBMTR) showing 50% survival through more than 4 years of follow-up for remestemcel-L treated patients in the Phase 3 trial for whom less than 20% survival at two years was expected based on disease severity. The resubmission also included a post-hoc propensity matched study showing 6 month survival was 67% with remestemcel-L vs 10% with other unapproved therapies in highest-risk patients as identified using the Mount Sinai Acute GVHD International Consortium (MAGIC). These pediatric data provide further support for use of remestemcel- L in the proposed study in high-risk adults with SR-aGVHD.
- Forums
- ASX - By Stock
- MSB
- Ann: Trading Halt
Ann: Trading Halt, page-1143
-
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.5¢ |
Change
-0.020(2.01%) |
Mkt cap ! $1.124B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 97.5¢ | $778.0K | 789.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 39291 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 47086 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 40000 | 0.975 |
17 | 221715 | 0.970 |
13 | 230892 | 0.965 |
11 | 585400 | 0.960 |
4 | 28366 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 50150 | 31 |
0.985 | 46237 | 13 |
0.990 | 69117 | 32 |
0.995 | 77668 | 5 |
1.000 | 92548 | 8 |
Last trade - 12.18pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |